Summary & Overview
HCPCS Level II J2010: Injection, Lincomycin HCl, up to 300 mg
HCPCS Level II code J2010 denotes an injectable dose of lincomycin hydrochloride, up to 300 mg. The code is used to bill for administration of this antibiotic in clinical settings where parenteral therapy is required. Nationally, accurate coding for antibiotic injections like J2010 supports appropriate payment, utilization tracking, and antimicrobial stewardship efforts.
Key payers considered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find succinct benchmarks for coverage and reimbursement patterns, discussion of relevant coding and billing considerations, and clinical context regarding when a parenteral lincomycin dose is applicable. The publication outlines common service settings for this injectable medication and highlights areas where payers commonly apply medical necessity review or specific documentation requirements.
The analysis provides practical reference material for billing staff, clinical coders, and revenue managers: it summarizes the clinical indication implied by the code description, typical sites of service, and payer coverage scope. Where specific payer policies or national-level updates exist, the publication summarizes those policy themes. Data not available in the input is identified as such and omitted from detailed tables.
Billing Code Overview
HCPCS Level II code J2010 describes an injection of lincomycin hydrochloride, up to 300 mg per administration. This code represents a single injectable dose of the antibiotic lincomycin used for treatment of susceptible bacterial infections.
Service Type: Therapeutic injection (antibiotic administration)
Typical Site of Service: Outpatient clinic, physician office, or hospital outpatient department
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an urgent care clinic or emergency department with signs of a serious gram-positive infection such as cellulitis, skin and soft tissue infection, or bone/joint infection in patients with penicillin allergy. The clinician documents history, physical exam, and orders parenteral antibiotic therapy. A licensed nurse or pharmacist prepares and administers J2010 (injection, lincomycin HCl, up to 300 mg) via intramuscular or intravenous route according to facility protocol. The service workflow includes verifying patient identity and allergies, confirming indication (for example, severe skin infection refractory to oral therapy or when oral route is contraindicated), obtaining informed consent for injectable therapy, completing medication administration record, monitoring for immediate adverse reactions for at least 30 minutes post‑injection, and documenting dose, lot number, route, site, and any patient response. Billing is submitted using J2010 with appropriate modifier(s) reflecting circumstances such as professional delivery, multiple procedures, or staffing situations. Typical sites of service are outpatient clinics, emergency departments, observation units, and inpatient wards when lincomycin is used as part of inpatient antimicrobial management.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |